Whole-genome sequencing reveals activation-induced cytidine deaminase signatures during indolent chronic lymphocytic leukaemia evolution
about
Integrative systems medicine approaches to identify molecular targets in lymphoid malignanciesThe Number of Overlapping AID Hotspots in Germline IGHV Genes Is Inversely Correlated with Mutation Frequency in Chronic Lymphocytic Leukemia.Mutational Strand Asymmetries in Cancer Genomes Reveal Mechanisms of DNA Damage and Repair.Somatic ERCC2 mutations are associated with a distinct genomic signature in urothelial tumors.Mutational landscape and underlying mutational processes in chronic lymphocytic leukemia.Phosphatidylinositol 3-kinase δ blockade increases genomic instability in B cellsComprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma.Whole-genome sequencing of chronic lymphocytic leukaemia reveals distinct differences in the mutational landscape between IgHVmut and IgHVunmut subgroups.RNA binding to APOBEC deaminases; Not simply a substrate for C to U editing.Genomic Evolution after Chemoradiotherapy in Anal Squamous Cell Carcinoma.Next-generation sequencing in chronic lymphocytic leukemia: recent findings and new horizons.Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer.Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors.Mutational signatures reveal the dynamic interplay of risk factors and cellular processes during liver tumorigenesis.Living Organisms Author Their Read-Write Genomes in Evolution.Hydrogen bonds are a primary driving force for de novo protein folding.Identification of abnormal nuclear and mitochondrial genes in esophageal cancer cells.Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia.Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas.Computational approaches for discovery of mutational signatures in cancer.Single-agent ibrutinib in relapsed or refractory follicular lymphoma: a phase 2 consortium trial.Can exome scans be expected to be part of real-time decision-making in patients with haematological cancers?Highly similar genomic landscapes in monoclonal B-cell lymphocytosis and ultra-stable chronic lymphocytic leukemia with low frequency of driver mutations.Characterizing genomic differences of human cancer stratified by the TP53 mutation status.Distinct mutational signatures characterize concurrent loss of polymerase proofreading and mismatch repair.Matrix Integrative Analysis (MIA) of Multiple Genomic Data for Modular Patterns.A multiple myeloma-specific capture sequencing platform discovers novel translocations and frequent, risk-associated point mutations in IGLL5.Gene expression profiling of periodontitis-affected gingival tissue by spatial transcriptomics.Identification of Distinct Unmutated Chronic Lymphocytic Leukemia Subsets in Mice Based on Their T Cell DependencyType 2 diabetes genetic loci informed by multi-trait associations point to disease mechanisms and subtypes: A soft clustering analysisGenomic patterns of progression in smoldering multiple myeloma
P2860
Q28067817-4FF911A5-7C97-454E-8018-82A0BE7885E8Q36261329-25A60F31-731E-499C-83C7-A6F491DF77A4Q36578527-8BF60681-D683-4040-91DF-D845977F4422Q37074346-DEFD7F0F-DA29-478E-B966-AB5946965D63Q37149398-65C71428-DFBD-468F-A607-0B27A77065B0Q38716411-CC04D9D8-E47D-4ADE-9F55-D6FC35FDD5AFQ38722204-0C45A460-52D6-4390-BEDC-551B80925262Q38742049-C5627241-A904-4F2D-A967-5D817F1F84DEQ39015203-A29A5462-FCBA-44AA-98A3-B9D1E5DC6A65Q39182541-BED56CCA-2A40-4327-912A-939F7D6C1282Q42378526-7BA091DA-64E8-4888-8CA8-71BAEB455D62Q42516513-67063FC2-727C-4199-8228-F03FA7FD3317Q43045850-1E47270D-2D19-49A3-99F3-A5B56B6FD65FQ43287348-B62CC043-42AD-49F1-84CE-7BB8ACF19BA5Q46246927-8673DB39-6754-4CAE-840F-383635945AACQ47130583-6E44053D-2BBB-46C3-9168-DBE2D30CA1EFQ47275966-2874D878-C5B4-4EA0-96A1-94B54DC2DEABQ47431964-8EAAB048-2756-4779-867D-4E0C3A0EAC73Q47444902-85BFB557-A737-41D2-A325-245C4FD9CB43Q47664589-E9AEDFC0-7F70-47C2-B405-DDD582047255Q47709959-32E19F70-E6B5-470C-879A-B850D3CBD0B6Q48183562-435046C2-A5A6-4D79-A26C-E3298C311289Q49959990-588589B8-2D8B-4BB3-AACF-0DE11BB2DB6EQ50057990-8257A9F3-AFF1-45B5-9CE9-C38C9C5B5257Q55025484-25470BE3-4D9D-451F-81B8-8AD5576987D9Q55119595-24AEC8AE-50AC-4F1C-B5DD-93DBB1FF58F2Q55313598-E28D5140-871E-403A-AF65-1F8E79D3C70EQ55347161-0630A77F-BF29-4BD5-999E-DC8043238424Q57110641-2B1CEEFA-4C8F-4B73-866E-24FF56CB001AQ58707548-76309223-9995-4B29-A991-B567B06BF4CFQ58721686-E2979859-19CB-4A9B-91F8-799E813C525B
P2860
Whole-genome sequencing reveals activation-induced cytidine deaminase signatures during indolent chronic lymphocytic leukaemia evolution
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Whole-genome sequencing reveal ...... ymphocytic leukaemia evolution
@ast
Whole-genome sequencing reveal ...... ymphocytic leukaemia evolution
@en
type
label
Whole-genome sequencing reveal ...... ymphocytic leukaemia evolution
@ast
Whole-genome sequencing reveal ...... ymphocytic leukaemia evolution
@en
prefLabel
Whole-genome sequencing reveal ...... ymphocytic leukaemia evolution
@ast
Whole-genome sequencing reveal ...... ymphocytic leukaemia evolution
@en
P2093
P2860
P356
P1476
Whole-genome sequencing reveal ...... ymphocytic leukaemia evolution
@en
P2093
E S Lander
M S Lawrence
N Haradhvala
P2860
P2888
P356
10.1038/NCOMMS9866
P407
P577
2015-12-07T00:00:00Z